Evidence quality 4.25/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 4/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 4/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 4/5
- D7 Perception honesty
- 3/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
Travelers to developing-country destinations widely know that gastrointestinal illness is a real risk, but many underestimate how probable it actually is for high-risk destinations like South Asia, Sub-Saharan Africa, and Mexico. Informal survey data from travel medicine clinics suggests most travelers heading to high-risk destinations estimate their per-trip risk at 10-20%, roughly half to one-third of the actual epidemiological range. The condition is also often dismissed as mild inconvenience, though a meaningful fraction of cases involve fever, bloody stools, or require antibiotic treatment.
Rough estimate: Most travelers to high-risk destinations guess 10-20% per trip
Source: editorial intuition, not polled
Actual
30-70% per 2-week trip to high-risk destinations
International travelers to high-risk destinations (South Asia, Sub-Saharan Africa, Mexico, Central America, parts of South America)
Show derivation
CDC Yellow Book 2024 states attack rates of 30-70% for travelers during a 2-week period to high-risk destinations (South/Central Asia, Sub-Saharan Africa, Mexico, Central and South America). The scope is activity_specific_lifetime: this figure represents the per-trip probability for a single 2-week trip to a high-risk destination, not a cumulative lifetime figure. The central estimate of 0.50 (50%) is the midpoint of the 30-70% published range. A Utah-based prospective study of international travelers (PMC9651512) found an incidence rate of 1.1 episodes per 100 travel-days in travelers departing for a mix of destinations, with Southeast Asian and African destinations associated with significantly higher odds. The lifetime_us_adult value here represents the per-trip probability (0.50) for a single high-risk-destination trip; it is not a conventional US adult lifetime accumulation. normalized.scope = activity_specific_lifetime documents this.
Caveats: The 30-70% attack rate is specifically for high-risk destinations (South/Central…
The 30-70% attack rate is specifically for high-risk destinations (South/Central Asia, Sub-Saharan Africa, Mexico, Central America) during a 2-week stay. Travelers to low-risk destinations (Western Europe, Japan, Australia, Canada) face rates below 5% per trip — essentially a different exposure category. The CDC definition of TD requires ≥3 unformed stools in 24 hours plus at least one enteric symptom; milder gastrointestinal disturbances are even more common. Most TD episodes are self-limiting within 1-5 days and require only rehydration; approximately 10% of cases involve fever, bloody stools, or require antibiotic treatment. Hemolytic uremic syndrome and post-infectious IBS are rare but real sequelae in a small fraction of cases. The entry does not cover food poisoning in the context of domestic US travel, which is addressed in other entries.
Related risks
Other risks on similar themes — for exploring related fears.
Traveler's diarrhea (water)
What are the odds of getting seriously ill from drinking water while traveling to a developing country?
Flying with cold
What are the odds of ear barotrauma or a ruptured eardrum from flying with a cold?
Adventure sports
What are the odds of a serious injury from regular participation in surfing, mountain biking, or rock climbing?
Drug-resistant infection
What is the risk of developing a serious antibiotic-resistant infection?
Inheriting AUD risk
If a parent had alcohol use disorder, what are the odds you'll develop alcohol use disorder yourself?
Decisions this risk informs
Choices that turn on this risk — how people weigh the trade-off.
Skip travel vaccines vs. take them
% who regret this choice
Action dominates
Action regret 5.0× higher
Pick challenger
Travelers’ diarrhea is the most common travel-related illness and one of the most predictable adverse events in international travel. The CDC Yellow Book 2024 puts the attack rate at 30-70% per two-week trip to high-risk destinations — South Asia, Sub-Saharan Africa, Mexico, and Central and South America. The midpoint of that range, roughly 1 in 2 trips to a high-risk destination, is substantially higher than most travelers’ intuitive estimate of 10-20%. Intermediate-risk destinations (Southeast Asia, Middle East) run 10-20% per trip, and low-risk destinations (Western Europe, Japan, Australia) fall below 5%.
The condition’s clinical course varies more than its reputation suggests. Most episodes are self-limiting within one to five days and require only oral rehydration; the stereotype of a brief unpleasant inconvenience is accurate for roughly 90% of cases. The remaining 10% involve fever, bloody stools, or symptoms persistent enough to warrant antibiotic treatment — and a small fraction of cases result in post-infectious irritable bowel syndrome, a condition that can persist for months after the original infection resolves. Bacteria dominate the etiology, with enterotoxigenic E. coli (ETEC), Campylobacter, and Salmonella accounting for the large majority of identifiable cases.
The attack-rate range reflects real and substantial heterogeneity in exposure. Behavioral precaution compliance is the strongest modifiable predictor: consistent avoidance of tap water (including ice), raw vegetables, and unpasteurized dairy reduces risk substantially. Budget travelers eating street food regularly face rates at the upper end of the range; travelers staying in international hotels with purified water throughout their stay face rates at the lower end or below it. Prophylactic rifaximin, used off-label by some travel medicine providers, demonstrates approximately 70% efficacy in controlled trials, though it is not universally recommended due to concerns about promoting antibiotic resistance.
Related tidbits
A single two-week trip to a high-risk destination carries a 30-70% chance of traveler's diarrhea, with a central estimate around 50% per trip. It is the most common travel-related illness, not a rare misfortune.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
1/3 sources independently verified verbatim against the cited source
-
[1] Centers for Disease Control and Prevention — Travelers' Diarrhea — CDC Yellow Book 2024
Travelers' Diarrhea — CDC Yellow Book 2024- Statistic
Attack rates 30-70% per 2-week trip to high-risk destinations (South/Central Asia, Sub-Saharan Africa, Mexico, Central and South America); 10-20% for intermediate-risk destinations (SE Asia, Middle East); <5% for low-risk destinations (Western Europe, Japan, Australia)- Excerpt
“"Attack rates range from 30%–70% of travelers during a 2-week period, depending on the destination and season of travel. The highest-risk destinations are in Asia (except for Japan and South Korea) as well as the Middle East, Africa, Mexico, and Central and South America." ”
- Source data from
- 2024-01-01
- Accessed
- 2026-05-14 · archived copy
- Calculation
- CDC Yellow Book attack-rate range: 30-70% per 2-week stay at high-risk destinations. Central estimate: 50% (midpoint). This is a per-trip figure, not a lifetime accumulation, and is used directly as normalized.lifetime_us_adult with scope: activity_specific_lifetime. The 10-20% range for intermediate-risk destinations is cited for context but not used in the primary calculation.
- Independence
- CDC Yellow Book is a government public health reference compiled by CDC travel medicine experts from peer-reviewed literature. It is the primary US clinical reference for travel medicine and is independent from pharmaceutical company prophylaxis studies and private travel insurer claims data.
-
[2] PMC / National Library of Medicine — Incidence Rate and Risk Factors Associated with Travelers' Diarrhea in International Travelers Departing from Utah, USA Verified
Incidence Rate and Risk Factors Associated with Travelers' Diarrhea in International Travelers Departing from Utah, USA- Statistic
23% of 484 surveyed travelers reported TD; incidence rate 1.1 episodes per 100 travel-days; Southeast Asian and African regions associated with significantly increased odds- Excerpt
“"Of 571 travelers who completed posttravel surveys, 484 (85%) answered the TD question, of which 111 (23%) reported TD, for an incidence rate of 1.1 episodes per 100 travel-days. Visiting Southeast Asian and African WHO regions, longer trip duration, visiting both urban and rural destinations were statistically significantly associated with increased odds of reporting TD." ”
- Source data from
- 2022-09-01
- Accessed
- 2026-05-14 · archived copy
- Verification
- Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
- Calculation
- The Utah study's 23% overall rate across mixed destinations (including low-risk destinations) is consistent with the CDC Yellow Book 30-70% high-risk range when accounting for the study population's destination mix. The 1.1 episodes per 100 travel-days translates to approximately 15 episodes per 100 travelers on a 14-day trip for the average study destination — below the CDC high-risk range because the study included many lower-risk destinations. Used to corroborate that the CDC range is epidemiologically supported; the CDC figure is used for the primary estimate.
- Independence
- This prospective cohort study surveyed travelers departing a single US university travel clinic, making it methodologically independent from CDC Yellow Book meta-analytic estimates. The study's population (Utah international travelers) may differ from the national average traveler in destination choice and demographic composition.
-
[3] Emerging Infectious Diseases (CDC) — Etiology and Epidemiology of Travelers' Diarrhea among US Military and Adult Travelers, 2018-2023
Etiology and Epidemiology of Travelers' Diarrhea among US Military and Adult Travelers, 2018-2023- Statistic
Bacterial pathogens account for >80% of TD cases; ETEC was the most identified E. coli pathotype in 5 of 6 countries; Campylobacter, Salmonella, and norovirus also identified as TD etiologies at lower proportions- Excerpt
“"Bacterial pathogens are the leading causative agents of TD, accounting for >80% of cases. ETEC was the most identified E. coli pathotype in 5 of 6 countries. Our investigation also identified Campylobacter, Salmonella, and norovirus as TD etiologies, although with lower proportions than observed for E. coli." ”
- Source data from
- 2024-10-01
- Accessed
- 2026-05-14 · archived copy
- Calculation
- Documents that the TD disease burden is dominated by bacterial pathogens (>80% of cases), led by ETEC, with Campylobacter, Salmonella, and norovirus contributing at lower proportions. This bacterial-dominance etiology supports why antibiotic prophylaxis and treatment (e.g. rifaximin, whose ~70% prophylactic efficacy figure is sourced from the CDC Yellow Book, not this article) are most effective. This article does not address rifaximin efficacy or antimicrobial-resistance trends.
- Independence
- Peer-reviewed CDC journal; data sources include US military surveillance and civilian travel clinic data, distinct from the CDC Yellow Book meta-analytic framework and the Utah cohort study.